BioTrinity

#BioTrinity #Investment #MHRA #Regulatory #UK

Key takes from BioTrinity 2026

DDW Editor Reece Armstrong attended day one of BioTrinity. Here he offers an overview of the conference and the themes to come out of it.   In an era of turbulence, BioTrinity stood out with an air of general positivity concerning the UK’s current standing within the life… Read More

#Business & Investment #Exclusive Content

Science connection and networking
#BioTrinity #Life sciences

OBN rebrands as BioUK to capitalise on life sciences success 

OBN has rebranded to BioUK to reflect its goal of catalysing on success in the UK life sciences sector.  The not-for-profit organisation says the updated brand identity has been developed to align with its position following a period of sustained growth, providing support throughout the UK to help R&D… Read More

#News

Science connection and networking
#Biopharmaceuticals #BioTrinity #Comment #Events #Funding #Investment #Life sciences

Reflecting on BioTrinity 2023  

BioTrinity 2023 marked the 17th annual edition of BioTrinity and took place in London, UK from Tuesday 25 April to Wednesday 26 April. DDW’s Megan Thomas spoke with attendees, and comments on the event.    Fundraising and investment   Coming out of a global pandemic, in-person events initially… Read More

#Exclusive Content

BioTrinity 2023
#BioTrinity #Conference #Events #Life sciences #London

BioTrinity 2023 will combine life science innovation and business

Life sciences membership organisation OBN (UK) will be holding in-person event BioTrinity 2023 in London on April 25-26. The conference will feature two tracks: ‘Scientific’, showcasing innovation across eight core therapy areas, and ‘Life Sciences Business & Investment’. Key features will include: Showcase presentations… Read More

#News